Print(PDF/144KB) Mar. 26, 2025 Finances

Notice Regarding Refinancing of Existing Borrowings Through a Syndicated Loan

Sumitomo Pharma Co., Ltd. (Head Office: Osaka, Japan; Representative Director, President, and CEO: Toru Kimura) announced today that as of today (March 26), the Company has decided to refinance its existing borrowings (hereinafter referred to as “the Refinancing”) through a syndicated loan (Tranche A: Term Loan, Tranche B: Commitment Line) (hereinafter referred to as “the Syndicated Loan Agreement”), as outlined below.

1. Purpose of the Refinancing

The Company has repaid a portion of existing borrowings, including a bridge loan for the acquisition of Myovant Sciences Ltd. as a wholly owned subsidiary and existing borrowings for the strategic alliance with Roivant Sciences Ltd. implemented in December 2019, totaling 331 billion yen, with the proceeds of 98 billion yen from the sale of Roivant Sciences Ltd. shares, and has entered into new syndicated loan agreements as detailed below. Through the Refinancing, the Company aims to resolve the breach of financial covenants that occurred in the fiscal year ended March 2024 and to stabilize its financial position.

2. Overview of the Syndicated Loan Agreement

Please scroll horizontally to view more information.

Term Loan
(Tranche A)
Commitment Line
(Tranche B)
Amount 140.0 billion JPY 93.0 billion JPY
Use of Funds Refinancing of existing borrowings Working capital
Loan/Commitment Period March 31, 2025 – March 31, 2028
Repayment Method Lump sum repayment on due date
Presence of Collateral None
Joint Guarantor Sumitomo Chemical Co., Ltd.
Arranger & Agent Sumitomo Mitsui Banking Corporation
Co-Arranger Sumitomo Mitsui Trust Bank, Limited
Participating Financial Institutions Sumitomo Mitsui Banking Corporation
Sumitomo Mitsui Trust Bank, Limited
The Norinchukin Bank
Mizuho Bank, Ltd.
MUFG Bank, Ltd.
The Hyakujushi Bank, Ltd.
Aozora Bank, Ltd.
The Iyo Bank, Ltd.
San ju San Bank, Ltd.
The Shiga Bank, Ltd.
Joyo Bank, Ltd.
The Hiroshima Bank, Ltd.
The Oita Bank, Ltd.
The Chiba Bank, Ltd.
The Nanto Bank, Ltd.
The Kiyo Bank, Ltd.

3. Future Outlook

The impact of this refinancing on the Company’s consolidated financial results for the fiscal year ending March 2025 is expected to be minimal.

Inquiries from the Press